Breast Cancer Therapeutics in Major Developed Markets Trends to 2021 2 | Page 6

5.16 Heat Map for Pipeline Products 68
6 Market Forecast to 2021 70
6.1 Geographical Markets 70
6.2 Global Market 70
6.3 North America 72
6.3.1 Treatment Usage Patterns 72
6.3.2 Annual Cost of Therapy 73
6.3.3 Market Size 74
6.4 Five Leading European Markets 75
6.4.1 Treatment Usage Patterns 75
6.4.2 Annual Cost of Therapy 77
6.4.3 Market Size 78
6.5 Japan 79
6.5.1 Treatment Usage Patterns 79
6.5.2 Annual Cost of Therapy 80
6.5.3 Market Size 81
7 Drivers and Barriers for the Disease Market 82
7.1 Drivers 82
7.1.1 Increased Uptake of Targeted and Combination Therapies for Breast Cancer 82
7.1.2 Growth and Aging of Western Populations 82
7.1.3 Launch of Premium-Priced Products with Greater Efficacy than Existing Therapies 82
7.2 Barriers 82
7.2.1 Patent Expiries 82
7.2.2 High Level of Competition 83
7.2.3 Problems with the Reimbursement of Premium-Priced Therapeutics will Limit their Uptake 83